TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Program Announcements For Studies On Blue Collar Workers, Children Released By DRCCA November 5, 1982